TrialOphthalmology2022

Bevacizumab in High-Risk Corneal Transplantation: A Pilot Multicenter Prospective Randomized Control Trial.

Thomas H Dohlman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.